O
37
-2
MCHP
52
3
EQIX
50
3
PRU
50
2
SIG
47
-3
ADBE
66
4
GIS
54
2
NTRS
39
2
IPG
42
-2
PM
52
-4
CRM
59
4
SYF
83
-3
GM
61
-4
AAPL
56
-3
AA
38
3
CAG
39
5
WU
24
-6
JNPR
56
2
CVX
23
-2
BBY
55
-2
O
37
-2
MCHP
52
3
EQIX
50
3
PRU
50
2
SIG
47
-3
ADBE
66
4
GIS
54
2
NTRS
39
2
IPG
42
-2
PM
52
-4
CRM
59
4
SYF
83
-3
GM
61
-4
AAPL
56
-3
AA
38
3
CAG
39
5
WU
24
-6
JNPR
56
2
CVX
23
-2
BBY
55
-2
Financhill
Back

Viasat Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
9

VSAT
Viasat

Last Price:
13.44
Seasonality Move:
-0.31%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
9
Viasat (VSAT) is a Sell

Is Viasat a Buy, Sell or Hold?

  • The current Viasat [VSAT] share price is $13.43. The Score for VSAT is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • VSAT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VSAT Stock Price Chart

What is Viasat's stock price today?

  • The Viasat share price today is $13.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VSAT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VSAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 35.31 Sell
Chaikin Money Flow: 1069536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.9 - 17.46) Sell
Bollinger Bands (100): (15.37 - 19.63) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

VSAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.74 Sell
20-day SMA: 15.03 Sell
50-day SMA: 16.13 Sell
200-day SMA: 19.67 Sell
8-day EMA: 13.86 Sell
20-day EMA: 14.87 Sell
50-day EMA: 16.09 Sell
200-day EMA: 20.7 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Viasat Earnings Growth & VSAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, an increase next quarter of $0.41 per share, a decrease this year of $1.42 per share, and a decrease next year of $1.34 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Viasat Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):